Are You Familiar with Analyst's Recommendation?: Walgreens Boots Alliance, Inc. (WBA)

It helps investors in determining whether buying, selling or holding on to a stock would be beneficial for them.

With an estimated value of 25.55 for 2017, Walgreens Boots Alliance, Inc. has a P/E ratio of 18.81. To clear the blur picture investors will need to look a little deeper. They issued a "hold" rating and a $78.00 price target on the stock. Hanson McClain Inc. boosted its position in Walgreens Boots Alliance by 4.6% in the 2nd quarter. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Cambridge Financial Group Inc. increased its position in shares of Walgreens Boots Alliance by 3.3% in the third quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator's stock worth $412,000 after purchasing an additional 21 shares during the period.

A number of other equities analysts also recently commented on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 83.10 on Monday.

The Leverage Ratio of Walgreens Boots Alliance, Inc.

According to 29 stock analysts, Costco Wholesale Corporation, is being kept at an average Outperform, rating, with at least 3.49% of shares outstanding that are now legally short sold.

The short ratio in the company's stock is documented at 2.99 and the short float is around of 2.78%.

Several other institutional investors have also sold shares of the company. Following the transaction, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The share price volatility of the stock remained at 2.06% for the month and by reducing the timeframe to just a week, the volatility stood at 1.56%. Following the completion of the transaction, the director now owns 50,000 shares of the company's stock, valued at $3,350,000. The disclosure for this purchase can be found here. The PEG ratio combines the regular P/E ratio with the company's expected earnings growth.

Looking about the past performance history, the company jumped -1.21% for the last five trades and expanded 7.75% in one month period. Its quick ratio for the most recent quarter is 0.60.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.10.

An earnings forecast is an analyst's outlook for a company's future quarterly or annual earnings.

With its market cap stated above, the dividend yield for Walgreens Boots Alliance, Inc., WBA is 2.25%. The company reported revenue of $0 in the same period past year. (WBA) have shown a high EPS growth of 9.40% in the last 5 years and has earnings decline of -1.10% yoy. Shareholders of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th.

ROA ratio indicates how profitable a company is relative to its total assets.

The outstanding shares for Walgreens Boots Alliance, 997.89 with a shares float of 863.83. Generally speaking a P/B ratio under 1 is considered low and is best used in relation to asset-heavy firms.

TRADEMARK VIOLATION NOTICE: "Walgreens Boots Alliance Inc (WBA) Shares Sold by Park National Corp OH" was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & worldwide trademark and copyright legislation. The correct version of this news story can be accessed at

"We have had a presence in China for around 10 years, initially through Alliance Boots, and we are excited about the opportunity to further invest in the country's fast growing retail pharmacy sector", he added. "It is China's leading pharmacy chain and we believe that we can positively contribute to its continued successful development with our global pharmacy expertise". It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).